- Report
- October 2024
- 195 Pages
Global
From €3383EUR$3,545USD£2,835GBP
€3759EUR$3,939USD£3,150GBP
- Report
- March 2025
- 200 Pages
Global
From €4285EUR$4,490USD£3,590GBP
- Drug Pipelines
- April 2024
- 60 Pages
Global
From €1909EUR$2,000USD£1,599GBP
- Report
- June 2024
- 200 Pages
Global
From €7587EUR$7,950USD£6,357GBP
- Report
- January 2022
- 60 Pages
Global
From €3770EUR$3,950USD£3,159GBP
- Report
- November 2023
- 174 Pages
Global
From €4295EUR$4,500USD£3,598GBP
- Report
- July 2022
- 41 Pages
Global
From €1909EUR$2,000USD£1,599GBP
Encephalitis is an inflammation of the brain caused by a virus or other infectious agent. Infectious Diseases Drugs are used to treat this condition, and the Encephalitis Drug market is a subset of this larger market. These drugs are used to reduce inflammation, reduce symptoms, and prevent further damage to the brain. They may also be used to treat complications such as seizures, coma, and death. Common drugs used to treat encephalitis include antivirals, corticosteroids, and immunosuppressants.
The Encephalitis Drug market is highly competitive, with many companies offering a variety of treatments. Some of the major players in this market include GlaxoSmithKline, Merck & Co., Pfizer, Sanofi, and Johnson & Johnson. Other companies include AstraZeneca, Novartis, and Bristol-Myers Squibb. Show Less Read more
